Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction

Inclusion Criteria: * Age 18 years and older of any gender or race * Written informed consent to participate in the study * Willingness and ability to return for all study visits * Positive history of self-reported dry eye symptoms for three months prior to the study using OSDI with a score of ≥ 23 at the baseline visit * Evidence of meibomian gland (MG) obstruction, based on total MGS of ≤12 in lower eyelids for each eye as assessed by a clinician not involved in the study procedure * Tear break-up time \<10 seconds * Agreement/ability to abstain from dry eye/MGD medications for the time between the screening visit and the final study visit (ocular lubricants are allowed if no changes are made during the study) Exclusion Criteria: * History of ocular or corneal surgery including intraocular, oculo-plastic, corneal or refractive surgery within 1 year * Subjects with giant papillary conjunctivitis * Subject with punctal plugs or who have had punctal cautery * Ocular injury or trauma, chemical burns, or limbal stem cell deficiency within 3 months of the baseline examination * Active ocular herpes zoster or simplex of eye or eyelid or a history of these within the last 3 months * Subjects who are aphakic * Cicatricial lid margin disease identified via slit lamp examination, including pemphigoid, symblepharon, etc. * Active ocular infection * Active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months * Ocular surface abnormality that …